Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Eisai
Biotech
Tortugas comes out of shell with $106M, 4 ph. 2-stage neuro meds
A pair of Sage veterans has launched a neurology startup armed with $106 million and a clinical-stage pipeline licensed from Eisai and Hansoh.
James Waldron
Apr 21, 2026 10:41am
Novo Holdings-backed biotech raises $205M to fill gout care gap
Sep 30, 2025 8:00am
Eisai's abandoned Enhertu challenger set to live on at BlissBio
Mar 21, 2025 7:20am
Bristol Myers culls cell therapy deals with 2 biotechs
Dec 16, 2024 11:19am
Eisai pays $46M for Japan rights to Newron's schizophrenia med
Dec 13, 2024 8:37am
Alzheimer's trials withheld brain injury risk disclosures: NYT
Oct 24, 2024 11:33am
